HUP0202414A2 - Új eljárás perindopril és analógjai, és ezek sói előállítására - Google Patents
Új eljárás perindopril és analógjai, és ezek sói előállításáraInfo
- Publication number
- HUP0202414A2 HUP0202414A2 HU0202414A HUP0202414A HUP0202414A2 HU P0202414 A2 HUP0202414 A2 HU P0202414A2 HU 0202414 A HU0202414 A HU 0202414A HU P0202414 A HUP0202414 A HU P0202414A HU P0202414 A2 HUP0202414 A2 HU P0202414A2
- Authority
- HU
- Hungary
- Prior art keywords
- compound
- general formula
- preparation
- formula
- alkyl group
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
- 229960002582 perindopril Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 8
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
Abstract
A találmány (IV) általános képletű vegyület vagy annak észtere, vagysója előállítására vonatkozik, oly módon, hogy 1) egy (I) általánosképletű vegyületet - ahol Ra jelentése 1-4 szénatomos alkilcsoport, Rbjelentése 1-4 szénatomos alkilcsoport, és Rc jelentése 1-6 szénatomosalkilcsoport egy X2C=O általános képletű vegyülettel - ahol a két Xegymástól függetlenül kilépőcsoportot jelent - reagáltatva egy (II)általános képletű vegyületet - ahol Ra, Rb és Rc jelentése a fentmegadott - állítanak elő; és 2) a kapott (II) általános képletűvegyületet egy (III) általános képletű vegyülettel - a képletben Rdjelentése hidrogénatom vagy védőcsoport reagáltatják. A találmány magában foglalja a (II) általános képletű vegyületeketés az (I) általános képletű vegyületek előálítására szolgáló eljárástis. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01500197 | 2001-07-24 |
Publications (3)
Publication Number | Publication Date |
---|---|
HU0202414D0 HU0202414D0 (hu) | 2002-09-28 |
HUP0202414A2 true HUP0202414A2 (hu) | 2003-02-28 |
HUP0202414A3 HUP0202414A3 (en) | 2003-05-28 |
Family
ID=8183486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202414A HUP0202414A3 (en) | 2001-07-24 | 2002-07-23 | Process for the preparation of perindopril, their analogous and their salts |
Country Status (24)
Country | Link |
---|---|
US (1) | US20040248814A1 (hu) |
EP (1) | EP1279665B1 (hu) |
JP (1) | JP4083118B2 (hu) |
KR (1) | KR100694528B1 (hu) |
CN (1) | CN100503568C (hu) |
AR (1) | AR036187A1 (hu) |
AT (1) | ATE386717T1 (hu) |
AU (1) | AU2002328954B2 (hu) |
BR (1) | BR0211422A (hu) |
CY (1) | CY1107403T1 (hu) |
DE (1) | DE60225092T2 (hu) |
DK (1) | DK1279665T3 (hu) |
EA (1) | EA007000B1 (hu) |
ES (1) | ES2300402T3 (hu) |
HK (1) | HK1067129A1 (hu) |
HU (1) | HUP0202414A3 (hu) |
MX (1) | MXPA04000649A (hu) |
NO (1) | NO20040278L (hu) |
NZ (1) | NZ530578A (hu) |
PL (1) | PL355161A1 (hu) |
PT (1) | PT1279665E (hu) |
SI (1) | SI1279665T1 (hu) |
WO (1) | WO2003010142A2 (hu) |
ZA (1) | ZA200400323B (hu) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2289060T3 (es) | 2002-01-30 | 2008-02-01 | Les Laboratoires Servier | Proceso para la preparacion de perindopril de alta pureza y de intermedios utiles en su sintesis. |
ES2307923T3 (es) | 2003-02-28 | 2008-12-01 | Les Laboratoires Servier S.A. | Procedimiento de preparacion de perindopril y sales del mismo. |
ES2386161T3 (es) | 2003-04-16 | 2012-08-10 | Bristol-Myers Squibb Company | Proceso para separar una mezcla de enantiómeros de éster alquílico usando una enzima |
SI21506A (sl) * | 2003-05-08 | 2004-12-31 | LEK farmacevtska dru�ba d.d. | Postopek za pripravo perindoprila |
SI21507A (sl) * | 2003-05-16 | 2004-12-31 | LEK farmacevtska dru�ba d.d. | Postopek za pripravo spojin z ace inhibitornim delovanjem |
AU2003263584A1 (en) * | 2003-08-21 | 2005-03-10 | Hetero Drugs Limited | Process for pure perindopril tert-butylamine salt |
AU2003300689B2 (en) * | 2003-10-21 | 2009-01-29 | Les Laboratoires Servier | Novel method for preparation of crystalline perindopril erbumine |
SI21703A (en) * | 2004-01-14 | 2005-08-31 | Lek Farmacevtska Druzba Dd | Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia |
SI21881A (sl) | 2004-10-15 | 2006-04-30 | Diagen, Smartno Pri Ljubljani, D.O.O. | Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine |
ES2255872B1 (es) * | 2004-12-31 | 2007-08-16 | Quimica Sintetica, S.A. | Procedimiento para la preparacion de perindopril erbumina. |
US7291745B2 (en) | 2005-03-21 | 2007-11-06 | Glenmark Pharmaceuticals Limited | Process for the preparation of perindopril |
JP2006290825A (ja) * | 2005-04-13 | 2006-10-26 | Shiono Chemical Co Ltd | アルファ型ペリンドプリルエルブミンの製造法 |
WO2006137082A1 (en) * | 2005-06-23 | 2006-12-28 | Ramesh Babu Potluri | Process for industrially viable preparation of perindopril erbumine |
FR2894825B1 (fr) * | 2005-12-21 | 2010-12-03 | Servier Lab | Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent |
US7960558B2 (en) | 2006-05-12 | 2011-06-14 | Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag | Pharmaceutical intermediate for synthesizing ACE inhibitors and the use thereof |
JP2008019214A (ja) * | 2006-07-13 | 2008-01-31 | Shiono Chemical Co Ltd | ペリンドプリルまたはその誘導体の製造方法 |
EP2150538B1 (en) | 2007-06-06 | 2012-03-28 | DSM Sinochem Pharmaceuticals Netherlands B.V. | Novel 5-substituted hydantoins |
FR2985512B1 (fr) | 2012-01-05 | 2014-06-20 | Servier Lab | Procede de preparation du sel de l-arginine du perindopril |
FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
CN111116709B (zh) * | 2019-12-31 | 2022-06-24 | 北京鑫开元医药科技有限公司 | 一种培哚普利制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2487829A2 (fr) * | 1979-12-07 | 1982-02-05 | Science Union & Cie | Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
US4508729A (en) * | 1979-12-07 | 1985-04-02 | Adir | Substituted iminodiacids, their preparation and pharmaceutical compositions containing them |
US4350704A (en) * | 1980-10-06 | 1982-09-21 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids |
LU88621I2 (fr) * | 1980-10-23 | 1995-09-01 | Schering Corp | Sandopril |
ZA817261B (en) * | 1980-10-23 | 1982-09-29 | Schering Corp | Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them |
US4558038A (en) | 1981-03-30 | 1985-12-10 | Usv Pharmaceutical Corp. | N-Substituted-amindo-amino acids |
US4496542A (en) * | 1981-03-30 | 1985-01-29 | Usv Pharmaceutical Corporation | N-substituted-amido-amino acids |
US4686295A (en) * | 1982-03-10 | 1987-08-11 | Usv Pharmaceutical Corporation | N-carboxy anhydride intermediates |
US4885293A (en) * | 1984-09-24 | 1989-12-05 | Schering Corporation | Antiglaucoma agents |
JPS6248696A (ja) | 1985-08-27 | 1987-03-03 | Kanegafuchi Chem Ind Co Ltd | N−〔1(s)−エトキシカルボニル−3−フエニルプロピル〕−l−アラニル−l−プロリンの製造法 |
ES2004804A6 (es) * | 1987-08-13 | 1989-02-01 | Pharma Investi S A | Un procedimiento para preparar derivados de carboxialquildipeptidos |
FR2620699B1 (fr) * | 1987-09-17 | 1990-06-01 | Adir | Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides |
FR2620703B1 (fr) * | 1987-09-17 | 1991-10-04 | Adir | Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides |
FR2620709B1 (fr) * | 1987-09-17 | 1990-09-07 | Adir | Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese |
FR2620700B1 (fr) * | 1987-09-17 | 1990-06-01 | Adir | Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides |
US5258525A (en) * | 1991-03-27 | 1993-11-02 | Mcneilab, Inc. | Processes for preparing [2S-(2α,3aβ,7aβ)]octahydro-1H-indole-2-carboxylic acid and esters |
SI9200213A (en) * | 1992-09-16 | 1994-03-31 | Krka | Process for preparing alkyl-l-alanil-l-proline derivates |
IN184759B (hu) | 1997-07-22 | 2000-09-23 | Kaneka Corp | |
SE0000382D0 (sv) * | 2000-02-07 | 2000-02-07 | Astrazeneca Ab | New process |
-
2002
- 2002-07-22 AR ARP020102743A patent/AR036187A1/es not_active Application Discontinuation
- 2002-07-23 AU AU2002328954A patent/AU2002328954B2/en not_active Ceased
- 2002-07-23 DE DE60225092T patent/DE60225092T2/de not_active Revoked
- 2002-07-23 NZ NZ530578A patent/NZ530578A/en not_active IP Right Cessation
- 2002-07-23 EA EA200400129A patent/EA007000B1/ru not_active IP Right Cessation
- 2002-07-23 ES ES02016262T patent/ES2300402T3/es not_active Expired - Lifetime
- 2002-07-23 PT PT02016262T patent/PT1279665E/pt unknown
- 2002-07-23 JP JP2003515501A patent/JP4083118B2/ja not_active Expired - Fee Related
- 2002-07-23 BR BR0211422-4A patent/BR0211422A/pt not_active IP Right Cessation
- 2002-07-23 DK DK02016262T patent/DK1279665T3/da active
- 2002-07-23 KR KR1020047001019A patent/KR100694528B1/ko not_active IP Right Cessation
- 2002-07-23 US US10/484,672 patent/US20040248814A1/en not_active Abandoned
- 2002-07-23 PL PL02355161A patent/PL355161A1/xx not_active Application Discontinuation
- 2002-07-23 SI SI200230668T patent/SI1279665T1/sl unknown
- 2002-07-23 CN CNB028143221A patent/CN100503568C/zh not_active Expired - Fee Related
- 2002-07-23 HU HU0202414A patent/HUP0202414A3/hu unknown
- 2002-07-23 EP EP02016262A patent/EP1279665B1/en not_active Revoked
- 2002-07-23 WO PCT/EP2002/008223 patent/WO2003010142A2/en active Application Filing
- 2002-07-23 AT AT02016262T patent/ATE386717T1/de active
- 2002-07-23 MX MXPA04000649A patent/MXPA04000649A/es active IP Right Grant
-
2004
- 2004-01-15 ZA ZA2004/00323A patent/ZA200400323B/en unknown
- 2004-01-21 NO NO20040278A patent/NO20040278L/no not_active Application Discontinuation
-
2005
- 2005-01-19 HK HK05100509.9A patent/HK1067129A1/xx unknown
-
2008
- 2008-04-21 CY CY20081100440T patent/CY1107403T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP4083118B2 (ja) | 2008-04-30 |
HK1067129A1 (en) | 2005-04-01 |
NO20040278L (no) | 2004-01-21 |
WO2003010142A2 (en) | 2003-02-06 |
BR0211422A (pt) | 2004-08-17 |
AR036187A1 (es) | 2004-08-18 |
NZ530578A (en) | 2007-02-23 |
ATE386717T1 (de) | 2008-03-15 |
EP1279665B1 (en) | 2008-02-20 |
ZA200400323B (en) | 2005-03-30 |
JP2005501829A (ja) | 2005-01-20 |
KR100694528B1 (ko) | 2007-03-13 |
AU2002328954B2 (en) | 2007-10-04 |
DE60225092T2 (de) | 2009-02-19 |
KR20040029378A (ko) | 2004-04-06 |
DK1279665T3 (da) | 2008-06-23 |
CN100503568C (zh) | 2009-06-24 |
CN1529694A (zh) | 2004-09-15 |
US20040248814A1 (en) | 2004-12-09 |
HU0202414D0 (hu) | 2002-09-28 |
HUP0202414A3 (en) | 2003-05-28 |
PT1279665E (pt) | 2008-03-28 |
PL355161A1 (en) | 2003-01-13 |
CY1107403T1 (el) | 2012-12-19 |
WO2003010142A3 (en) | 2003-08-28 |
EP1279665A3 (en) | 2003-03-12 |
EP1279665A2 (en) | 2003-01-29 |
SI1279665T1 (sl) | 2008-06-30 |
MXPA04000649A (es) | 2004-10-27 |
DE60225092D1 (de) | 2008-04-03 |
ES2300402T3 (es) | 2008-06-16 |
EA007000B1 (ru) | 2006-06-30 |
EA200400129A1 (ru) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202414A2 (hu) | Új eljárás perindopril és analógjai, és ezek sói előállítására | |
HUP0303756A2 (hu) | 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények | |
MA27040A1 (fr) | Nucleosides substitues en 4' | |
HUP0201385A2 (hu) | Eljárás a 4"-szubsztituált 9-dezoxo-9a-aza-9a-homoeritromicin-A-származékok előállítására | |
DE69615808D1 (de) | Camphothecinderivate | |
HUP0100615A2 (hu) | Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére | |
IL148631A0 (en) | Quinuclidine derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
DE69823648D1 (de) | 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4) | |
EE200200148A (et) | Kinasoliini derivaadid, nende valmistamise meetodning kasutamine | |
AU3599701A (en) | Fluorescent probes for the quantitation of zinc | |
HUP0203520A2 (hu) | Bisz-acil-amidokat tartalmazó szilárd kozmetikai vagy gyógyszerészeti készítmény | |
CA2368095A1 (en) | Process for preparing inhibitors of nucleoside metabolism | |
HUP0204563A2 (en) | Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions | |
HUP9801946A2 (hu) | 5-HT-felvétel-inhibitorból és szelektív 5-H1A-antagonistából álló kombinációs gyógyászati készítmény és eljárás előállítására | |
CA2210492A1 (en) | Neuraminic acid derivatives, their preparation and their medical use | |
HUP0203117A2 (hu) | Semleges kationos lipid nukleinsav és hatóanyag szállítására | |
RS20060239A (en) | Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics | |
HUP0201083A2 (hu) | Új atorvastatinsók és az azokat tartalmazó gyógyszerkészítmények | |
SE0203070D0 (en) | Novel compounds | |
TW427979B (en) | A condensed piperidine compound | |
HUP9901212A2 (hu) | N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk | |
TR200100286T2 (tr) | (1H)-Benzo[C]kuinolizin-3-on türevlerinin sentezi için proses. | |
HUP9801056A2 (hu) | Apolipoprotein-B szintézist gátló triazolonszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
JP2002544191A5 (hu) | ||
KR890016059A (ko) | 포스포노알킬퓨린 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |